The US food and drug administration perspective on cancer biomarker development

被引：141
|
作者：
Gutman, Steven
Kessler, Larry G.
机构：
[1] US FDA, Off In Vitro Diagnost Devices, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
[2] US FDA, Off Sci, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
[3] US FDA, Engn Labs, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
来源：
NATURE REVIEWS CANCER | 2006年 / 6卷 / 07期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1038/nrc1911
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite the intense interest in biomarker development for cancer management, few biomarker assays for diagnostic uses have been submitted to the US Food and Drug Administration (FDA). What challenges must researchers overcome to bring cancer-detection technologies to the market and, therefore, into clinical use?
引用
收藏
页码：565 / 571
页数：8
相关论文
共 50 条
  • [31] CLINICAL EVIDENCE SUPORTING PHARMACOGENOMIC BIOMARKER TESTING PROVIDED IN US FOOD AND DRUG ADMINISTRATION DRUG LABELS: AN UPDATE
    Baradaran, S.
    Keyloun, K. R.
    Chin, L.
    Pham, J.
    Canestaro, W.
    Devine, B.
    VALUE IN HEALTH, 2016, 19 (03) : A289 - A289
  • [32] US Food and Drug Administration's Approval of Aripiprazole Tablets With Sensor: Our Perspective
    Lee, Daniel J.
    Farchione, Tiffany R.
    Mathis, Mitchell V.
    Muniz, Javier
    Muoio, Brendan M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2018, 79 (03)
  • [33] Role of controlled human malaria infection (CHMI) in malaria vaccine development: A US food & drug administration (FDA) perspective
    Chattopadhyay, Rana
    Pratt, Douglas
    VACCINE, 2017, 35 (21) : 2767 - 2769
  • [34] Drug Safety in Labeling for Pediatric Drug Development and Dose Selection in Submissions to the US Food and Drug Administration
    Kim, Clara
    Park, Kyunghun
    McMahon, Ann W.
    Green, Francis G.
    Green, Dionna J.
    Burckart, Gilbert J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 : S133 - S140
  • [35] Surgical Innovation and the US Food and Drug Administration
    Cundiff, Geoffrey W.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2019, 25 (04): : 263 - 264
  • [36] US Food and Drug Administration pushed to change
    McCarthy, M
    LANCET, 2006, 367 (9523): : 1643 - 1644
  • [37] Increasing Transparency at the US Food and Drug Administration
    Steinbrook, Robert
    JAMA INTERNAL MEDICINE, 2019, 179 (08) : 1146 - 1147
  • [38] The US Food and Drug Administration and Emergency Contraception
    Fox, Anthony W.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL MEDICINE, 2005, 19 (03): : 139 - 140
  • [39] Crisis deepens at the US Food and Drug Administration
    Lenzer, J
    BRITISH MEDICAL JOURNAL, 2004, 329 (7478): : 1308 - 1308
  • [40] US Food and Drug Administration gets it right
    Grove, ML
    BRITISH MEDICAL JOURNAL, 2002, 325 (7367): : 776 - 776
12345